Streetbeat News

Products Services

VTLE

Vital Energy has increased its FY24 production guidance from 116.5-121.5 MBOE/d to 127.0-131.0 MBOE/d, indicating a positive outlook for the company's operational performance.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:49 pm

PAAS

Pan American Silver (PAAS) has announced its silver production forecast for 2024, estimating between 21 million to 23 million ounces.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:45 pm

JOBY

Joby Aviation, Inc. (NYSE:JOBY) shares rose after the company reported its Q2 financial results. The company met analyst expectations with a GAAP loss of 18 cents per share and reported a net loss of $123.3 million. Joby highlighted progress in aircraft certification and flew a hydrogen-electric air taxi demonstrator 561 miles. The company also acquired the autonomy division of Xwing.

Portfolio Pulse from Erica Kollmann

August 07, 2024 | 9:44 pm

TTI

TETRA Technologies, Inc. (NYSE: TTI) has completed a Definitive Feasibility Study (DFS) for its Arkansas Bromine Project, upgrading previously announced bromine resources to reserves. The study indicates a Net Present Value (NPV) of $710 million for a vertically integrated production case, compared to $337 million for third-party bromine purchases. The project is expected to increase TETRA's revenue by $200-$250 million and Adjusted EBITDA by $90-$115 million. The project will be funded through existing credit facilities and cash flow, with a projected payback period of 5.7 years.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:43 pm

JNJ

Johnson & Johnson announced positive results from the Phase 2 UNITY study of nipocalimab for treating pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN). The study, published in The New England Journal of Medicine, showed that 54% of participants achieved a live birth at or after 32 weeks without the need for intrauterine transfusion. Nipocalimab is currently the only therapy in clinical development for HDFN.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:41 pm

ATS

ATS Corporation (NYSE:ATS) has announced a definitive agreement to acquire Heidolph Group, a leading manufacturer of premium lab equipment for the life sciences and pharmaceutical industries. Financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:40 pm

GNSS

Genasys has signed a $75 million agreement with the Puerto Rico Electric Power Authority to implement an emergency warning system across 37 dams. The project is fully funded by FEMA to enhance public safety.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:39 pm

CRM

G

Genpact has integrated with Salesforce Data Cloud to deliver AI-driven industry solutions, aiming to unlock data-driven insights and transform operations.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:37 pm

SPCE

Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares rose after the company reported better-than-expected Q2 results. The company posted a quarterly loss of $4.36 per share, beating estimates by 11.56%, and revenue of $4.22 million, surpassing estimates by 25.56%. The net loss improved to $94 million from $134 million in the same period last year. The company also made significant progress on its Delta Class spaceship program.

Portfolio Pulse from Erica Kollmann

August 07, 2024 | 9:35 pm

AMRX

Amneal Pharmaceuticals shares are trading higher after the company announced that the FDA approved CREXONT extended-release capsules for the treatment of Parkinson's disease.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:34 pm